10 hrs ago | BusinessWeek
Movers: Fannie Mae, Freddie Mac, Wachovia, Lehman, J&J, Genentech
Shares of U.S. mortgage giants Freddie Mac and Fannie Mae are seen lower due to concerns that their rescue plan might hurt the equity stakes of current shareholders, according to Reuters newswire.
Nonclinical studies addressing the mechanism of action of trastuzumab (Herceptin).
In normal biological systems, HER2 functions as a co-receptor for a multitude of epidermal growth factor-like ligands that bind and activate other HER family members.
Genentech Says Profit Rises 4.7% on Avastin Sales, Raises Annual Forecast
Genentech Inc., the biggest U.S. maker of cancer drugs, raised its 2008 forecast and said second- quarter profit increased 4.7 percent on higher sales of its Avastin treatment for colon, lung and breast tumors.
Analyst initiations: SOLF, BMRN and DNA
MOST NOTEWORTHY: Solarfun Power, BioMarin Pharmaceutical and Genentech were today's noteworthy initiations: Jefferies initiated Solarfun Powe r with a Buy rating and $18 target.
Avastin Cancer Drug Linked To Anemia In Combo Trials Doctors Warned
Main Category: Clinical Trials / Drug Trials Also Included In: Cancer / Oncology On Monday, the US Food and Drug Administration posted on its website, a copy of a letter from Genentech Inc, the makers of cancer ...
Genentech, Inc. Ends Studies on Drug Combo Safety Issue
Biotechnology company Genentech Inc. ended several studies combining its cancer drug Avastin and Pfizer Inc.'s Sutent because several patients developed a type of anemia.
Company Warns Against Off-Label Use of Bevacizumab
Genentech Inc. recently released a warning against an off-label use of bevacizumab, according to a FDA MedWatch notice.
SchaeffersResearch.com Daily Market Blog
Genentech (DNA) Reports 2Q Earnings, Ups Full-Year Guidance
The company reported second-quarter profit of $782 million, or 73 cents per share, compared to $747 million, or 70 cents per share, a year prior.
Analyst Actions: Wachovia, Genentech
Oppenheimer analyst Meredith Whitney downgrades Wachovia despite the already dramatic decline in the shares and the fact it trading below tangible book value of $13.60, based upon her dramatically diminished ...
Before the bell: LEH, DNA, AIG, KMB, LEN, AAPL
Before the bell: Futures tumble on financials, ahead of data, earnings Genentech Inc.
Israel Cabinet OKs prisoner swap with Hezbollah
The swap is due to take place on Wednesday under U.N. supervision at a seaside border crossing.
FDA MedWatch- Avastin (bevacizumab) and Sunitinib Malate- Reports of...
Genentech, Inc. informed healthcare professionals of reports of several cases of microangiopathic hemolytic anemia in patients with solid tumors receiving Avastin in combination with sunitinib malate.
After Hours: Genentech, Novellus Systems slated to release results
Shares of biotechnology sector heavyweight Genentech Inc. and chip-equipment maker Novellus Systems Inc.
Zacks Analyst Blog Highlights: Sangamo Biosciences, Dow AgroSciences, ...
Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.
NeoVista takes on Genentech with eye surgery device
A tiny Fremont company with a single eye surgery device in a late-stage trial has mighty Genentech Inc.
Earnings Preview: Monday through Wednesday
As we do each earnings period, here are the names I'm watching as earnings season begins in earnest Tuesday.
How to Succeed When the Market's Down
There's really just one reason you invest in stocks : to make money. But when the investing climate doesn't cooperate, it's just as important to lose less when markets are falling as it is to make more when ...
Stocks to Watch: Stocks in focus for Monday
Among the companies whose shares are expected to see active trade in Monday's session are Genentech Inc.
The San Francisco Business Times
The rehabilitation of Kirk Raab is complete. Deposed as CEO of biotech giant Genentech Inc.
Inspect Herceptin Cartons for Damaged, Broken Vials
Genentech Inc. in the past year has received more than the usual number of complaints of damaged and broken vials of Herceptin and its accompanying diluent, according to a company letter circulated today by ...